Summary
Two encephalomyocarditis virus (EMCV) neutralizing monoclonal antibodies (MAs), recognizing different determinants on EMCV, were both able to protect mice prophylactically and therapeutically against a lethal dose of EMCV.
References
Balachandran N, Bacchetti S, Rawls WE (1982) Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Infect Immun 37: 1132–1137
Boere WAM, Benaissa-Trouw BJ, Harmsen M, Kraaijeveld CA, Snippe H (1983) Neutralizing and non-neutralizing monoclonal antibodies to the E2 glycoprotein of Semliki Forest Virus can protect mice from lethal encephalitis. J Gen Virol 64: 1405–1408
Boere WAM, Harmsen M, Vinjé J, Benaissa-Trouw B, Kraaijeveld CA, Snippe H (1984) Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities. J Virol 52: 575–582
Boere WAM, Benaissa-Trouw BJ, Harmsen T, Erich T, Kraaijeveld CA, Snippe H (1985) Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus. J Virol 54: 546–551
Bogaerts WJC (1971) Respiratory immunization against EMC virus in mice. Academic Thesis, Utrecht
Bogaerts WJC, Durville-van der Oord BJ (1973) Immunization of mice with live attenuated encephalomyocarditis virus: local immunity and survival. Infect Immun 8: 528–533
Carter MJ, Ter Meulen V (1984) The application of monoclonal antibodies in the study of viruses. Adv Virus Res 29: 95–130
Craighead JE (1965) Some properties of the encephalomyocarditis, Columbia SK and mengo viruses. Proc Soc Exp Biol Med 119: 408–412
Craighead JE (1975) The role of viruses in the pathogenesis of pancreatic disease and diabetes mellitus. Prog Med Virol 19: 161–214
Ey PL, Prowse SJ, Jenkin CR (1978) Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose. Immunochemistry 15: 429–436
Fazekas de St. Groth S, Scheidegger D (1980) Production of monoclonal antibodies: strategy and tactics. J Immunol Methods 35: 1–21
Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495–497
Kohler G, Howe SW, Milstein C (1976) Fusion between immunoglobulin-secreting and non-secreting myeloma cell lines. Eur J Immunol 6: 292–295
Kraaijeveld CA, La Rivière G, Benaissa-Trouw BJ, Jansen J, Harmsen M, Snippe H (1983) Effect of the adjuvant dimethyl dioctadecyl ammonium bromide on the humoral and cellular immune responses to encephalomyocarditis virus. Antiviral Res 3: 137–149
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275
Murphy BR, Glasgow LA (1968) Factors modifying host resistance to infection. III. Effect of whole body x-irradiation in mice. J Exp Med 127: 1035–1052
Nakane PK, Kawaoi A (1974) Peroxidase-labeled antibody, a new method of conjugation. J Histochem Cytochem 22: 1084–1091
Pollock RR, Teilland JL, Scharff MD (1984) Monoclonal antibodies: a powerful tool for selecting and analyzing mutations in antigens and antibodies. Ann Rev Microbiol 38: 389–417
Putnak JR, Philips BA (1981) Picornaviral structure and assembly. Microbiol Rev 45: 287–315
Schmaljohn AL, Johnson ED, Dalrymple JM, Cole GA (1982) Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature 297: 70–72
Stave JW, Card JL, Morgan DO (1986) Analysis of foot-and mouth disease virus type O1 Brugge. Neutralization epitopes using monoclonal antibodies. J Gen Virol 67: 2083–2092
Yewdell JW, Gerhard W (1981) Antigenic characterization of viruses by monoclonal antibodies. Ann Rev Microbiol 35: 185–206
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vlaspolder, F., Kraaijeveld, C.A., van Buuren, R. et al. Prophylaxis and therapy of virulent encephalomyocarditis virus infection in mice by monoclonal antibodies. Archives of Virology 98, 123–130 (1988). https://doi.org/10.1007/BF01321013
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01321013